Terje Svingen, Emilie Elmelund, Marie L Holmer, Anna O Bindel, Henrik Holbech, Monica K Draskau
{"title":"AOP report: Adverse Outcome Pathway Network for Developmental Androgen Signalling-Inhibition Leading to Short Anogenital Distance in Male Offspring.","authors":"Terje Svingen, Emilie Elmelund, Marie L Holmer, Anna O Bindel, Henrik Holbech, Monica K Draskau","doi":"10.1093/etojnl/vgaf221","DOIUrl":null,"url":null,"abstract":"<p><p>This report outlines an adverse outcome pathway network (AOPN) linking reduced androgen signalling during the fetal masculinization programming window to shortened anogenital distance (AGD) at birth. In mammals such as mice, rats, and humans, the AGD is approximately twice as long in males as in females, driven by androgen-dependent differentiation of the male phenotype. Impaired androgen signalling during fetal development can lead to a significantly shorter AGD in male offspring, a sexually dimorphic feature widely used in rodent toxicity studies and human epidemiological research to assess exposure to anti-androgenic substances. AGD measurement is an endpoint in several OECD Test Guideline studies for reproductive toxicity. Notably, androgen signalling can be perturbed by various molecular initiating events, and capturing these causal toxicological pathways may facilitate the use of non-animal test data to help inform predictive toxicology by describing the mechanistic knowledge required for hazard and risk assessment of chemicals. The AOPN includes three AOPs all converging on the same adverse outcome of 'reduced AGD' but with distinct upstream pathways. The upstream portion of the AOPN includes more generalized key events (KEs) and key event relationships (KERs) with broad applicability domains, many of which are measurable by well-established in vitro methods. In contrast, the downstream events have a narrower applicability domain, focusing on development of the perineal region and AGD in male offspring. This report provides overall assessments of AOPs 305, 306, and 307, including one new KE (2298) and four new KERs (2127, 3448, 3449, 3349) not previously reported. The overall confidence for all three AOPs are moderate-to-high with few inconsistencies or uncertainties. The taxonomic domain of the AOPN is mammals, with most evidence coming from mouse, rat and human studies. The upstream network capturing the molecular events has broad taxonomic applicability to all mammals and could likely be extended to some other vertebrates.</p>","PeriodicalId":11793,"journal":{"name":"Environmental Toxicology and Chemistry","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental Toxicology and Chemistry","FirstCategoryId":"93","ListUrlMain":"https://doi.org/10.1093/etojnl/vgaf221","RegionNum":4,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
This report outlines an adverse outcome pathway network (AOPN) linking reduced androgen signalling during the fetal masculinization programming window to shortened anogenital distance (AGD) at birth. In mammals such as mice, rats, and humans, the AGD is approximately twice as long in males as in females, driven by androgen-dependent differentiation of the male phenotype. Impaired androgen signalling during fetal development can lead to a significantly shorter AGD in male offspring, a sexually dimorphic feature widely used in rodent toxicity studies and human epidemiological research to assess exposure to anti-androgenic substances. AGD measurement is an endpoint in several OECD Test Guideline studies for reproductive toxicity. Notably, androgen signalling can be perturbed by various molecular initiating events, and capturing these causal toxicological pathways may facilitate the use of non-animal test data to help inform predictive toxicology by describing the mechanistic knowledge required for hazard and risk assessment of chemicals. The AOPN includes three AOPs all converging on the same adverse outcome of 'reduced AGD' but with distinct upstream pathways. The upstream portion of the AOPN includes more generalized key events (KEs) and key event relationships (KERs) with broad applicability domains, many of which are measurable by well-established in vitro methods. In contrast, the downstream events have a narrower applicability domain, focusing on development of the perineal region and AGD in male offspring. This report provides overall assessments of AOPs 305, 306, and 307, including one new KE (2298) and four new KERs (2127, 3448, 3449, 3349) not previously reported. The overall confidence for all three AOPs are moderate-to-high with few inconsistencies or uncertainties. The taxonomic domain of the AOPN is mammals, with most evidence coming from mouse, rat and human studies. The upstream network capturing the molecular events has broad taxonomic applicability to all mammals and could likely be extended to some other vertebrates.
期刊介绍:
The Society of Environmental Toxicology and Chemistry (SETAC) publishes two journals: Environmental Toxicology and Chemistry (ET&C) and Integrated Environmental Assessment and Management (IEAM). Environmental Toxicology and Chemistry is dedicated to furthering scientific knowledge and disseminating information on environmental toxicology and chemistry, including the application of these sciences to risk assessment.[...]
Environmental Toxicology and Chemistry is interdisciplinary in scope and integrates the fields of environmental toxicology; environmental, analytical, and molecular chemistry; ecology; physiology; biochemistry; microbiology; genetics; genomics; environmental engineering; chemical, environmental, and biological modeling; epidemiology; and earth sciences. ET&C seeks to publish papers describing original experimental or theoretical work that significantly advances understanding in the area of environmental toxicology, environmental chemistry and hazard/risk assessment. Emphasis is given to papers that enhance capabilities for the prediction, measurement, and assessment of the fate and effects of chemicals in the environment, rather than simply providing additional data. The scientific impact of papers is judged in terms of the breadth and depth of the findings and the expected influence on existing or future scientific practice. Methodological papers must make clear not only how the work differs from existing practice, but the significance of these differences to the field. Site-based research or monitoring must have regional or global implications beyond the particular site, such as evaluating processes, mechanisms, or theory under a natural environmental setting.